MastodonTech.de

Deutschland<a href="https://www.europesays.com/de/157220/" rel="nofollow noopener" translate="no" target="_blank">https://www.europesays.com/de/157220/</a> Todesfälle durch Medikament Promethazin: EU Warnhinweis veröffentlicht #100633310 <a href="https://pubeurope.com/tags/AktuelleNachrichten" class="mention hashtag" rel="nofollow noopener" target="_blank">#AktuelleNachrichten</a> <a href="https://pubeurope.com/tags/AktuelleNews" class="mention hashtag" rel="nofollow noopener" target="_blank">#AktuelleNews</a> <a href="https://pubeurope.com/tags/Allergie" class="mention hashtag" rel="nofollow noopener" target="_blank">#Allergie</a> <a href="https://pubeurope.com/tags/BfArM" class="mention hashtag" rel="nofollow noopener" target="_blank">#BfArM</a> <a href="https://pubeurope.com/tags/EMA" class="mention hashtag" rel="nofollow noopener" target="_blank">#EMA</a> <a href="https://pubeurope.com/tags/EU" class="mention hashtag" rel="nofollow noopener" target="_blank">#EU</a> <a href="https://pubeurope.com/tags/Europa" class="mention hashtag" rel="nofollow noopener" target="_blank">#Europa</a> <a href="https://pubeurope.com/tags/Europ%C3%A4ischeUnion" class="mention hashtag" rel="nofollow noopener" target="_blank">#EuropäischeUnion</a> <a href="https://pubeurope.com/tags/Europe" class="mention hashtag" rel="nofollow noopener" target="_blank">#Europe</a> <a href="https://pubeurope.com/tags/EuropeanUnion" class="mention hashtag" rel="nofollow noopener" target="_blank">#EuropeanUnion</a> <a href="https://pubeurope.com/tags/Fieber" class="mention hashtag" rel="nofollow noopener" target="_blank">#Fieber</a> <a href="https://pubeurope.com/tags/Headlines" class="mention hashtag" rel="nofollow noopener" target="_blank">#Headlines</a> <a href="https://pubeurope.com/tags/Nachrichten" class="mention hashtag" rel="nofollow noopener" target="_blank">#Nachrichten</a> <a href="https://pubeurope.com/tags/Nebenwirkung" class="mention hashtag" rel="nofollow noopener" target="_blank">#Nebenwirkung</a> <a href="https://pubeurope.com/tags/News" class="mention hashtag" rel="nofollow noopener" target="_blank">#News</a> <a href="https://pubeurope.com/tags/PRAC" class="mention hashtag" rel="nofollow noopener" target="_blank">#PRAC</a> <a href="https://pubeurope.com/tags/Schlafst%C3%B6rung" class="mention hashtag" rel="nofollow noopener" target="_blank">#Schlafstörung</a> <a href="https://pubeurope.com/tags/Schlagzeilen" class="mention hashtag" rel="nofollow noopener" target="_blank">#Schlagzeilen</a> <a href="https://pubeurope.com/tags/Todesfall" class="mention hashtag" rel="nofollow noopener" target="_blank">#Todesfall</a> <a href="https://pubeurope.com/tags/Warnhinweis" class="mention hashtag" rel="nofollow noopener" target="_blank">#Warnhinweis</a> <a href="https://pubeurope.com/tags/Wirkstoff" class="mention hashtag" rel="nofollow noopener" target="_blank">#Wirkstoff</a>

Deutschland<a href="https://www.europesays.com/de/138137/" rel="nofollow noopener" translate="no" target="_blank">https://www.europesays.com/de/138137/</a> Promethazin Todesfälle: Neuer EU-Warnhinweis für Medikament #100633310 <a href="https://pubeurope.com/tags/Allergie" class="mention hashtag" rel="nofollow noopener" target="_blank">#Allergie</a> <a href="https://pubeurope.com/tags/BfArM" class="mention hashtag" rel="nofollow noopener" target="_blank">#BfArM</a> <a href="https://pubeurope.com/tags/Deutschland" class="mention hashtag" rel="nofollow noopener" target="_blank">#Deutschland</a> <a href="https://pubeurope.com/tags/EMA" class="mention hashtag" rel="nofollow noopener" target="_blank">#EMA</a> <a href="https://pubeurope.com/tags/Fieber" class="mention hashtag" rel="nofollow noopener" target="_blank">#Fieber</a> <a href="https://pubeurope.com/tags/Germany" class="mention hashtag" rel="nofollow noopener" target="_blank">#Germany</a> <a href="https://pubeurope.com/tags/Gesundheit" class="mention hashtag" rel="nofollow noopener" target="_blank">#Gesundheit</a> <a href="https://pubeurope.com/tags/health" class="mention hashtag" rel="nofollow noopener" target="_blank">#health</a>+ <a href="https://pubeurope.com/tags/Nebenwirkung" class="mention hashtag" rel="nofollow noopener" target="_blank">#Nebenwirkung</a> <a href="https://pubeurope.com/tags/PRAC" class="mention hashtag" rel="nofollow noopener" target="_blank">#PRAC</a> <a href="https://pubeurope.com/tags/Schlafst%C3%B6rung" class="mention hashtag" rel="nofollow noopener" target="_blank">#Schlafstörung</a> <a href="https://pubeurope.com/tags/Todesfall" class="mention hashtag" rel="nofollow noopener" target="_blank">#Todesfall</a> <a href="https://pubeurope.com/tags/Warnhinweis" class="mention hashtag" rel="nofollow noopener" target="_blank">#Warnhinweis</a> <a href="https://pubeurope.com/tags/Wirkstoff" class="mention hashtag" rel="nofollow noopener" target="_blank">#Wirkstoff</a>

EU Health - #HealthUnionRT EU Medicines Agency EMA’s <a href="https://respublicae.eu/tags/safety" class="mention hashtag" rel="nofollow noopener" target="_blank">#safety</a> committee, the <a href="https://respublicae.eu/tags/PRAC" class="mention hashtag" rel="nofollow noopener" target="_blank">#PRAC</a>, is reviewing data on the risk of suicidal thoughts and thoughts of self-harm with GLP-1 receptor agonists used for weight loss and for treating type 2 <a href="https://respublicae.eu/tags/diabetes" class="mention hashtag" rel="nofollow noopener" target="_blank">#diabetes</a>. Read more in the news announcement: <a href="https://www.ema.europa.eu/en/news/ema-statement-ongoing-review-glp-1-receptor-agonists" rel="nofollow noopener" target="_blank">https://www.ema.europa.eu/en/news/ema-statement-ongoing-review-glp-1-receptor-agonists</a> <a href="https://t.co/Rf3Ly9FGbM" rel="nofollow noopener" target="_blank">https://t.co/Rf3Ly9FGbM</a> 🐦🔗: <a href="https://n.respublicae.eu/EMA_News/status/1678794781256761346" rel="nofollow noopener" target="_blank">https://n.respublicae.eu/EMA_News/status/1678794781256761346</a>

EU Medicines AgencyEMA's <a href="https://respublicae.eu/tags/safety" class="mention hashtag" rel="nofollow noopener" target="_blank">#safety</a> committee, the <a href="https://respublicae.eu/tags/PRAC" class="mention hashtag" rel="nofollow noopener" target="_blank">#PRAC</a>, carried out its work to assess all aspects of risk management related to the use of <a href="https://respublicae.eu/tags/medicines" class="mention hashtag" rel="nofollow noopener" target="_blank">#medicines</a>. More information in our meeting highlights: <a href="https://www.ema.europa.eu/en/news/meeting-highlights-pharmacovigilance-risk-assessment-committee-prac-3-6-july-2023" rel="nofollow noopener" target="_blank">https://www.ema.europa.eu/en/news/meeting-highlights-pharmacovigilance-risk-assessment-committee-prac-3-6-july-2023</a> <a href="https://respublicae.eu/tags/SafetyOfMedicines" class="mention hashtag" rel="nofollow noopener" target="_blank">#SafetyOfMedicines</a> <a href="https://t.co/D0EHywwIMF" rel="nofollow noopener" target="_blank">https://t.co/D0EHywwIMF</a> 🐦🔗: <a href="https://n.respublicae.eu/EMA_News/status/1677261762968662016" rel="nofollow noopener" target="_blank">https://n.respublicae.eu/EMA_News/status/1677261762968662016</a>

EU Medicines AgencyAt its June meeting, EMA's <a href="https://respublicae.eu/tags/safety" class="mention hashtag" rel="nofollow noopener" target="_blank">#safety</a> committee, the <a href="https://respublicae.eu/tags/PRAC" class="mention hashtag" rel="nofollow noopener" target="_blank">#PRAC</a>, carried out its work to assess all aspects of risk management related to the use of <a href="https://respublicae.eu/tags/medicines" class="mention hashtag" rel="nofollow noopener" target="_blank">#medicines</a>.More information in our meeting highlights: <a href="https://www.ema.europa.eu/en/news/meeting-highlights-pharmacovigilance-risk-assessment-committee-prac-5-8-june-2023" rel="nofollow noopener" target="_blank">https://www.ema.europa.eu/en/news/meeting-highlights-pharmacovigilance-risk-assessment-committee-prac-5-8-june-2023</a><a href="https://respublicae.eu/tags/SafetyOfMedicines" class="mention hashtag" rel="nofollow noopener" target="_blank">#SafetyOfMedicines</a> 🐦🔗: <a href="https://n.respublicae.eu/EMA_News/status/1667127819984306176" rel="nofollow noopener" target="_blank">https://n.respublicae.eu/EMA_News/status/1667127819984306176</a>

EU Medicines AgencyIf an unusual pattern emerged, the <a href="https://respublicae.eu/tags/PRAC" class="mention hashtag" rel="nofollow noopener" target="_blank">#PRAC</a> performed an in-depth analysis of the reports to quickly identify potential safety issues with <a href="https://respublicae.eu/tags/Covid19vaccines" class="mention hashtag" rel="nofollow noopener" target="_blank">#Covid19vaccines</a>. The 🇪🇺 pharmacovigilance system showed that it can detect and manage emerging <a href="https://respublicae.eu/tags/safety" class="mention hashtag" rel="nofollow noopener" target="_blank">#safety</a> issues quickly. <a href="https://respublicae.eu/tags/EMAPresser" class="mention hashtag" rel="nofollow noopener" target="_blank">#EMAPresser</a> 🐦🔗: <a href="https://n.respublicae.eu/EMA_News/status/1666080058241581057" rel="nofollow noopener" target="_blank">https://n.respublicae.eu/EMA_News/status/1666080058241581057</a>

EU Medicines AgencyWe placed extra obligations on the <a href="https://respublicae.eu/tags/Covid19vaccine" class="mention hashtag" rel="nofollow noopener" target="_blank">#Covid19vaccine</a> makers. They had to provide us with detailed monthly reports on the <a href="https://respublicae.eu/tags/safety" class="mention hashtag" rel="nofollow noopener" target="_blank">#safety</a> of their vaccine ➡️ 5⃣6⃣monthly reports were assessed by our safety committee, the <a href="https://respublicae.eu/tags/PRAC" class="mention hashtag" rel="nofollow noopener" target="_blank">#PRAC</a>, until December 2022. <a href="https://respublicae.eu/tags/EMAPresser" class="mention hashtag" rel="nofollow noopener" target="_blank">#EMAPresser</a> 🐦🔗: <a href="https://n.respublicae.eu/EMA_News/status/1666079498784366597" rel="nofollow noopener" target="_blank">https://n.respublicae.eu/EMA_News/status/1666079498784366597</a>

Frühere Suchanfragen

Suchoptionen

Verwaltet von:

Serverstatistik:

#PRAC